Demand for domestic reference materials, the volume of laboratory testing and the uptake of full‑cycle R&D services demonstrate the technological self‑sufficiency and independence of Russian companies, the National Centre for Reference Standards (NCSS) said.
In the first half of the year, sales of certified reference materials rose 45% compared with the same period last year.
“The key growth driver is the industry’s active shift to Russian reference materials, which are becoming a reliable alternative to foreign analogues by offering high quality, products recognised under Russian and EAEU regulations, full support at every stage of use and shorter delivery times,” said Elena Tereshchuk, deputy general director for commercial affairs.
The company also noted that its laboratory services division is continuing to expand. In the first half of the year, the centre performed 30% more laboratory tests than in the same period of 2025.
A key milestone in the centre’s development was the spin‑off of its full‑cycle R&D centre as a standalone business unit. While the new structure officially launched in April 2026, it builds on existing expertise – development work had been underway for some time, and rising demand from manufacturers made a dedicated competence centre necessary.
The R&D division is now actively engaged in solving practical industry challenges. The centre’s portfolio includes two finished dosage form developments and two projects to create alternative synthesis routes for active pharmaceutical ingredients as part of localisation efforts. This approach allows the centre to strengthen manufacturers’ technological independence and provide full‑cycle project support at every stage of development, the company said.
The centre’s key advantage is its “one‑stop‑shop” model: manufacturers receive comprehensive project support – from brief and development through to a ready‑to‑use technological solution – delivered by a single team of experts.
In the first half of 2026, the comparative dissolution kinetics test was the most sought‑after laboratory service at NCSS. The growing demand reflects an increase in generic drug development and registration projects, as well as manufacturers’ need for high‑quality analytical support when bringing products to market.